EPISODE · Nov 16, 2021 · 59 MIN
Episode 57: A Journey Through Lung Cancer History With Govindan Ramaswamy
from Healthcare Unfiltered · host Chadi Nabhan
Ramaswamy Govindan, MD, Anheuser Busch Endowed Chair in Medical Oncology, Washington University School of Medicine in St. Louis, provides the condensed oral history of thoracic oncology – dating from the late 1990s to the present day. Chadi and Dr. Govindan discuss how stage III chemoradiation and PET scans were new strategies before the turn of the century, the introduction of gefitinib as a pivotal moment in the treatment paradigm, the doors opening for EGFR inhibitors, the discovery of ALK as a targetable mutation, how genome sequencing in the 2010s opened additional targets, PD-1 and PD-L1 inhibition, and so much more.Check out Chadi’s website for all Healthcare Unfiltered episodes and other content. www.chadinabhan.com/Watch all Healthcare Unfiltered episodes on Youtube. www.youtube.com/channel/UCjiJPTpIJdIiukcq0UaMFsA
Embed this episode
What this episode covers
Ramaswamy Govindan, MD, Anheuser Busch Endowed Chair in Medical Oncology, Washington University School of Medicine in St. Louis, provides the condensed oral history of thoracic oncology – dating from the late 1990s to the present day. Chadi and Dr. Govindan discuss how stage III chemoradiation and PET scans were new strategies before the turn of the century, the introduction of gefitinib as a pivotal moment in the treatment paradigm, the doors opening for EGFR inhibitors, the discovery of ALK...
NOW PLAYING
Episode 57: A Journey Through Lung Cancer History With Govindan Ramaswamy
No transcript for this episode yet
Similar Episodes
No similar episodes found.